Background/Aims: The aim of this study was to identify the profile of rare variants associated with Crohn's disease (CD) using whole exome sequencing (WES) analysis of Korean children with CD and to evaluate whether genetic profiles could provide information during medical decision making. Methods: DNA samples from 18 control individuals and 22 patients with infantile, very-early and early onset CD of severe phenotype were used for WES. Genes were filtered using panels of inflammatory bowel disease (IBD)-associated genes and genes of primary immunodeficiency (PID) and monogenic IBD. Results: Eighty-one IBD-associated variants and 35 variants in PID genes were revealed by WES. The most frequently occurring variants were carried by nine (41%) and four (18.2%) CD probands and were ATG16L2 (rs11235604) and IL17REL (rs142430606), respectively. Twenty-four IBD-associated variants and 10 PID variants were predicted to be deleterious and were identified in the heterozygous state. However, their functions were unknown with the exception of a novel p.Q111X variant in XIAP (X chromosome) of a male proband. Conclusions: The presence of many rare variants of unknown significance limits the clinical applicability of WES for individual CD patients. However, WES in children may be beneficial for distinguishing CD secondary to PID. (Gut Liver 2015;9:767-775) 
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INTRODUCTION
Recent advances in genome-wide association studies (GWAS) and meta-analyses have identified 140 susceptibility loci for Crohn's disease (CD), an intestinal chronic inflammatory disease, in Caucasians; [1] [2] [3] [4] however, the currently identified loci explain less than 30% of the heritable risk and account for relatively small increments in the risk of inflammatory bowel disease (IBD). Existing GWAS have focused on common variants (minor allele frequency [MAF] >0.05), so strategies to enhance the identification of rare (MAF <0.01) and low-frequency (MAF, 0.01 to 0.05) variants with increasing effect sizes are critical for the discovery of the remaining inherited factors. 5 Direct genotyping by targeted array, metabochip, immunochip using low-frequency variants, and genome sequencing are the methods currently available to investigate disease-causing rare variants linked to complex traits. 6 Genome seuquencing technologies have developed rapidly in recent years and this strategy can be used for a wide range of investigations, from monogenic Mendelian disorders to diseases with high degrees of genetic heterogeneity. The human exome constitutes less than 5% of the genome, and whole exome sequencing (WES) studies can therefore be more cost effective than whole genome sequencing for focused research. In addition, protein-coding regions are more evolutionarily conserved and are more sensitive to genetic changes 7, 8 than nongenetic regions, making WES potentially more valuable for uncovering deleterious mutations. WES has been recently employed to circumvent the "diagnostic odyssey" by providing genetic diagnoses for hearing loss, muscular dystrophy, neuromuscular disease, retinitis pigmentosa, and mitochondrial disease. Mitochondrial disease was particularly notable because it was associated not only with mitochondrial genes, but also with hundreds of nuclear DNA genes. 9 Recently, a variety of primary immunodeficiencies (PIDs) and monogenic diseases were revealed to cause refractory infantile colitis. 10, 11 Therefore, WES is rapidly becoming a common clinical test for individuals with rare genetic disorders. 12, 13 Despite these advances, the ability of WES models to uncover disease-causing variants associated with complex conditions, such as CD and type 2 diabetes, has not been established for all populations. 14, 15 Methods such as GWAS have been used to validate whether identified high-effect variants are common enough to be carried by large populations with CD. Rare and low-frequency variants may occur too infrequently to be identified as contributory for complex traits. In addition, genotypical and phenotypical differences exist between Caucasian and Asian populations with CD. For example, mutations within the nucleotide-binding-oligomerisation-domain (NOD2/CARD15) and autophagy-related 16-like 1 (ATG16L1) sequences were not associated with CD in Asian populations. [16] [17] [18] In addition, the prevalence of small bowel involvement and perianal fistula was higher in Asian patients than in Caucasian patients. 19, 20 Herein, we used WES analysis of Korean children with CD with the aim of identifying rare variants associated with CD. Genetic susceptibility plays a more important role in the etiology of pediatric CD than adult CD, probably as a consequence of a higher burden of disease-causing mutations in affected children. 21 We therefore focused on patients with early-onset CD and severe symptoms such as more extensive disease at onset and rapid progression. In addition, we also asked whether genetic profiling of variants could assist in the medical decisionmaking process to determine optimal treatment of pediatric CD.
MATERIALS AND METHODS

Study population
Twenty-two early-onset CD cases were diagnosed at the IBD Clinic of the Seoul Asan Medical Center. The basic characteristics and clinical phenotypes of the study subjects are summarized in Table 1 . Among 230 CD children <14 years of age, youngest children with severe phenotype were included. The severe phenotype was defined as Pediatric Crohn's Disease Activity Index scores were >30 and simple endoscopic scores for CD were >20 at the time of diagnosis. Independent DNA samples from unrelated individuals were collected and sequenced for use as reference exomes to allow evaluation of the burden of mutation in patient samples. Reference exomes were from controls with no history of gastrointestinal or autoimmune disease. Informed consent was obtained from the parents of all the patients and the study was approved by the local ethics committees.
Whole exome sequencing
The WES analysis pipeline involved quality checks, alignments, and annotation to identify nucleotides that differed between the patient and reference sequences. 22 
Panels of genes associated with IBD and PID
To prioritize rare IBD-associated variants of potentially high impact, a comprehensive panel of known IBD-associated genes was selected from previous GWAS IBD data [1] [2] [3] [4] and from our GWAS database for Korean-specific susceptibility genes (ATG16L2, DUSP5, and TBC1D1). 24, 25 The comprehensive list contained 267
IBD genes, and was used for cross-referencing with exome data from patients and controls (Supplementary Table 1 ). One-fourth of very young IBD or IBD-mimic colitis cases are related to lossof-function mutations in critical immune genes, and variants in known PID genes were therefore analyzed to exclude PID in patients with CD. 26 A comprehensive panel of 236 PID genes was assembled according to the 2014 report from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency and Monogenic IBD genes (Supplementary  Table 2 ). 10, 11 The specific variants in PID and monogenic IBD gene panels were classified according to the OMIM database (http://omim.org).
Prediction of potential functionality
Three in silico prediction algorithms were used to predict the effect of each amino acid change on protein function.
27-29 SIFT (sorts intolerant from tolerant substitutions) and/or PolyPhen2 (polymorphism phenotyping 2) ratings of "deleterious" indicated a predicted disease-causing effect. A Mutation-Taster prediction of "disease-causing" was subsequently used as a more detailed pathogenicity score. A higher PhyloP score was indicative of higher levels of evolutionary conservation. 30 In this study, highly conserved loci (PhyloP score ≥1.5) were considered to have potentially deleterious mutations if a rating of "deleterious" or "disease-causing" resulted from at least one of the three in silico prediction models.
RESULTS
Exome sequencing
Exome data were analyzed from 22 pediatric patients with CD and 18 reference individuals. Total read average was 78,473,095 bp. Seventy-eight percent of mappable reads were on-target reads and 86% of targeted bases were covered at 10× read depth. Each exome had, on average, 66,289 SNPs, with 20,196 found in exonic regions. Following a series of qualitycontrol steps (SNP quality >50, total read depth >10, alternative read depth >3), 171,898 variants were identified across the 40 exomes. Of those, we focused on 32,794 missense/nonsense/ indel variants within exons. After 24,317 of these variants were removed due to their presence in the 18 control exomes, 8,477 unique variants from 5,625 genes were identified across 22 CD exomes.
Characteristics of coding variants in IBD-associated genes
Of the 8,477 unique variants from 5,625 genes, the 22 probands carried 81 rare and low-frequency variants, of which MAF were less than 0.05 among 56 IBD-associated genes (Supplementary Table 3 ). Two probands each carried nonsense mutations in ATG16L1 and NOD2; however, these were not deleterious and were not highly conserved according to in silico prediction algorithms. With the exception of ATG16L2 (rs11235604) and TBC1D1 (rs117452860), 24 the remaining variants were of unknown significance (VUS), and their functional roles in mucosal immunity remain to be elucidated. Among the 81 variants of the 56 IBD-associated genes, the most frequently occurring variants were carried by nine and four CD probands, and were found in ATG16L2 (rs11235604) and IL17REL (rs142430606), respectively (Table 2) . ATG16L2, a homolog of ATG16L1, was identified as a novel candidate gene for CD in a recent Korean GWAS. 24 ATG16L1 functions in autophagy alongside ATG5. 31 In addition, ATG16L1 is closely related to NOD2, which functions in an autophagy-mediated antibacterial pathway in CD. 32 However, little is known regarding the function of mutated ATG16L2. An additional SNP in IL17REL, rs142430606 (c.C785T; p.P262L), has not previously been associated with IBD and was not predicted to be deleteri- . . ous through in silico prediction. Variant rs5771069 was previously associated with ulcerative colitis. 33 However, there is no linkage disequilibrium between rs5771069 and rs142430606. The association of ATG16L2 and IL17REL with CD was confirmed using an internal CD GWAS database (n=533 Table 4) . 24 The newly identified variant (rs142430606 in IL17REL) showed a marginal association with CD (OR, 2.04; 95% CI, 1.001 to 4.14; imputed p-value=4.53×10 -2 ). Twenty-four unique deleterious variants (10 low-frequency SNPs and 14 novel variants) in 21 genes were identified in the 22 probands (Table 3 ). The 10 low-frequency SNPs have not previously been reported as associated with IBD. All the variants were in evolutionarily conserved regions of IBD-associated genes; however, it remains to be determined whether heterozygous incidence is deleterious for these variants. No dose effects have previously been reported for these genes with respect to CD phenotypes.
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Characteristics of coding variants in PID and monogenic IBD genes
Using a PID and monogenic IBD gene panel, 35 variants in 24 PID genes were identified in the 22 probands and among the 35 variants, 10 variants in eight PID genes were predicted to be deleterious (Table 4) ; however, all the variants were VUS in the heterozygous state with the exception of XIAP (p.Q111X; XIAP deficiency), which were identified on the X chromosome of a male patient (proband 13). The XIAP protein plays an important role in activating the nuclear factor κB signaling pathway that leads to proinflammatory cascades. 34 The stopgain mutation (c.C331T; p.Q111X) in proband 13 was confirmed by Sanger sequencing (Fig. 1) and was strongly indicative of XIAP deficiency. The mutation was located prior to the BIR2 and BIR3 domains, which play a role in the recruitment of RIP2 and apoptosis. 35 Proband 13 was diagnosed as having severe CD with perianal fistula at the age of 10 years. He presented reduced natural killer cell activity and recurrent episodes of bicytopenia with bacterial infections. A deleterious p.V561M variant in CYBB, of which can cause chronic granulomatous disease, was identified in proband 7. However, his respiratory burst tests were normal.
Correlation of patient profiles with deleterious variants
Comorbidity of perianal issues in the 22 CD probands was related to the presence of a heterozygous variant (rs11235604) in ATG16L2 (p<0.002, chi-square test); however, proband 16, who was homozygous for the rs11235604 variant, did not suffer perianal problems. Probands 5 and 9 died of severe infantile IBD and perianal fistula at the age of 14 months and 8 years, respectively. These two probands carried a heterozygous variant of IL10RA (c.C301T; p.R101W), which was previously reported to be a causative gene for refractory infantile IBD when present in the homozygous state. 36 We therefore performed Sanger sequencing on IL10RA in the two probands and their healthy parents; however, no additional homozygote or compound heterozygote mutations in IL10RA were identified. In summary, no genotype-phenotype associations were noted in the probands with the exception of XIAP deficiency in proband 13.
DISCUSSION
In this study, we performed WES analysis on samples from 22 children with CD, and identified 81 IBD-associated gene variants and 35 PID genes. One variant, rs11235604 in ATG16L2, was already identified as a CD susceptibility locus in our GWAS database. 24 A further variant, rs142430606 in IL17REL, was newly identified as a probable disease-causing rare variant. The GWAS dataset confirmed this variant to be marginally associated with CD (OR, 2.04; imputed p-value=4.53×10 -2 ). PID genes were also examined, and a novel p.Q111X variant in XIAP was noted in a patient with CD. The majority of the rare variants, particularly 24 unique deleterious variants in conserved loci, were VUS. Further study is needed to determine the functional effects of these mutations. The identification of numerous VUS in the small study population suggests that WES might not yet be applicable to clinical decision making in the treatment of pediatric CD.
One possible explanation for the difficulties in interpreting interesting rare variants is that IBD-associated variants are too rare and genetically heterogeneous to allow statistically significant observation in a small population. Recent GWAS successfully found common disease-causing variants in populations with CD, [1] [2] [3] [4] but those common variants accounted for less than 30% of the heritability of CD. 37 The majority of polymorphisms in the human genome are rare variants, but, due to the limited statistical power, the effects of rare variants on polygenic CD are not clear. The scope of our study was additionally limited by the challenges presented by WES analysis. 8, 38 First, WES involves applied computational genomics. Different sequencing methods produce sequences of varying length and depth and the results of "loss-of-function" predictions can vary with data formats and annotation software. In addition, detection of short sequence indels is limited to one third of the read length in WES. The very large amount of data required for WES analysis also poses a challenge in determining disease-causing mutations. Capturing specific genomic regions and the exome may reduce the complexity of the data and simplify the computational analysis.
In the present study, the analysis was simplified by prioritizing IBD-associated genes from recent GWAS studies and genes of PID and monogenic IBD. Second, in silico prediction models show substantial disagreements. 39 In the present study, we used three programs to assess the deleterious extent of the identified mutations. SIFT predictions correlated with Polyphen-2 and Mutation-Taster predictions at levels of 40% to 67%. Care must be taken to avoid false hypotheses that primarily rely on current filtering parameters and variable interpretations of WES data. 38 Therefore, in addition to validation by Sanger sequencing, func- tional studies are important for the full assessment of deleterious variants; however, it is difficult to perform functional studies on the numerous variants presented in the current study. The identification of numerous VUS does not alleviate the "diagnostic odyssey" needed for some patients. Nonetheless, based on the fact that IBD-mimicking colitis is frequently observed in immunodeficient infants, WES-based diagnosis for patients with monogenic IBD may be clinically practical. 26 The identification of mutations in IL10RA and XIAP by WES highlighted the need for hematopoietic stem cell transplantation in affected children. 40, 41 One-third of chronic granulomatous disease and one-fifth of XIAP-deficient patients develop a noninfectious chronic IBD similar to CD. 42, 43 Common variable immune deficiency, dyskeratosis congenita, immunodysregulation polyendocrinopathy enteropathy X-linked syndrome, and Wiskott-Aldrich syndrome are also frequently accompanied by infantile enterocolitis. 26 Using a panel of PID and monogenic IBD genes, our WES identified a novel XIAP variant carried by proband. 13 Detailed guidelines for the diagnosis of IBD using WES remain to be established. In conclusion, although pediatric patients with severe phenotypes carried a wide spectrum of genetic susceptibility factors for CD, the numerous heterozygous VUS in IBD-associated genes remain to be functionally characterized. Subsequently, those VUS limit the practical clinical application of WES for CD patients and hamper any personalized application of our findings to individual CD patients; however, using WES, a Koreanspecific variant in ATG16L2 was found in CD patients with early-onset and severe phenotype, and a probable candidate variant in IL17REL was newly identified. In addition, WES in children may be beneficial for distinguishing CD secondary to PID, for example as a result of the loss of XIAP protein.
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